Turning Point Therapeutics, Inc. EBITDA 2019-2022 | TPTX
Turning Point Therapeutics, Inc. ebitda from 2019 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Turning Point Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2021 | $-229 |
| 2020 | $-158 |
| 2019 | $-78 |
| 2018 | $-26 |
| 2017 | $-17 |
| Turning Point Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2022-06-30 | $-123 |
| 2022-03-31 | $-73 |
| 2021-12-31 | $-76 |
| 2021-09-30 | $-64 |
| 2021-06-30 | $-54 |
| 2021-03-31 | $-34 |
| 2020-12-31 | $-46 |
| 2020-09-30 | $-18 |
| 2020-06-30 | $-32 |
| 2020-03-31 | $-62 |
| 2019-12-31 | $-23 |
| 2019-09-30 | $-22 |
| 2019-06-30 | $-18 |
| 2019-03-31 | $-14 |
| 2018-12-31 | $-9 |
| 2018-09-30 | $-6 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-5 |
